Research Advisory

Annual Progress Report

The Panel Office is required to monitor all current ongoing Schedule I and Schedule II controlled substance research activity in California. In order to accomplish this, the Panel requires an annual Progress Report from each approved study site, to be forwarded to the Panel office no later than 25 days after the end of each year (i.e. every January 25th).

The report may be brief; however, it should include:

The Panel also requires notification of completion, and a final report, to be forwarded to the Panel office when each study is completed.